Accretion Pharmaceuticals IPO Timeline
The Accretion Pharmaceuticals IPO opened for subscription on Wednesday, 14 May 2025, and closed successfully on Friday, 16 May 2025.
The basis of allotment was finalized on Monday, 19 May 2025. Refunds to unsuccessful applicants were initiated on Tuesday, 20 May 2025, and shares were credited to the Demat accounts of successful investors on the same day.
The Accretion Pharmaceuticals IPO was listed on the NSE SME Platform on Wednesday, 21 May 2025, completing the IPO process.
Accretion Pharmaceuticals IPO Important Dates
- IPO Open Date: 14 May 2025
- IPO Close Date: 16 May 2025
- Basis of Allotment: 19 May 2025
- Refund Initiation: 20 May 2025
- Shares Credited to Demat: 20 May 2025
- Listing Date: 21 May 2025
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Accretion Pharmaceuticals IPO Timeline (Tentative)
- IPO Open Date
- Wednesday, 14 May 2025
- IPO Close Date
- Friday, 16 May 2025
- Basis of Allotment
- Monday, 19 May 2025
- Initiation of Refunds
- Tuesday, 20 May 2025
- Credit of Shares to Demat
- Tuesday, 20 May 2025
- Listing Date
- Wednesday, 21 May 2025 — NSE & BSE
Important Dates
Open Date
14 May 2025
Close Date
16 May 2025
Basis Of Allotment
19 May 2025
Listing Date
21 May 2025
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
When will the Accretion Pharmaceuticals IPO open for subscription?
The Accretion Pharmaceuticals IPO subscription opened on Wed, May 14, 2025 and closed on Fri, May 16, 2025.
What is the Accretion Pharmaceuticals IPO Allotment Date?
The Accretion Pharmaceuticals IPO allotment date was Mon, May 19, 2025. Investors can check their Accretion Pharmaceuticals IPO allotment status on the registrar's website using their PAN, application number, or DP/Client ID once the allotment is finalized.
What is the Accretion Pharmaceuticals IPO Listing Date?
The Accretion Pharmaceuticals IPO was listed on the NSE on Wed, May 21, 2025.
When will Accretion Pharmaceuticals IPO shares be credited to the Demat account?
The shares allotted in the Accretion Pharmaceuticals IPO were credited to Demat accounts of successful applicants on Tue, May 20, 2025.
What is the complete Accretion Pharmaceuticals IPO timeline?
The Accretion Pharmaceuticals IPO timeline began with the IPO opening for subcription on Wed, May 14, 2025 and closing on Fri, May 16, 2025. The basis of allotment was finalized on Mon, May 19, 2025. Refunds were initiated, and shares were credited to successful applicants' Demat accounts on Tue, May 20, 2025. The Accretion Pharmaceuticals IPO listed on the NSE on Wed, May 21, 2025.
What is the 'Pre-Apply' facility for the Accretion Pharmaceuticals IPO?
The Pre-Apply facility allows investors to submit their Accretion Pharmaceuticals IPO application up to 2 days before the IPO subscription opens. Your application is saved in advance and will be submitted when the IPO bidding window begins.
If I pre-apply for Accretion Pharmaceuticals IPO, when will my order get placed?
If you pre-apply for the Accretion Pharmaceuticals IPO, your order is submitted to the stock exchange once the IPO subscription window opens. After the bidding period begins, you will typically receive a UPI mandate request within 24 hours. Your IPO application is considered complete after you approve the UPI mandate and the required funds are blocked in your bank account.